News and Trends 25 Jul 2022Bavarian Nordic gets European monkeypox approval for smallpox vaccine Danish company Bavarian Nordic A/S says the European Commission (EC) has extended the marketing authorization for the company’s smallpox vaccine,… July 25, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2020Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step closer to commercializing the first… June 9, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2019Update: First Ever Ebola Vaccine Gets US and EU Approval Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval for its Ebola vaccine, the… December 20, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2018Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine Bavarian Nordic and AstraZeneca collaborate on a treatment that uses a cancer vaccine along with a checkpoint inhibitor to treat… February 28, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 25 Jul 2017Trouble in Paradise: How Biotech is Fighting Tropical Diseases Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech is preparing for the next… July 25, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2017Danish Biotech Reports Positive Phase II data for a Common Cold Vaccine Bavarian Nordic has announced positive Phase II results for its universal vaccine against the common cold virus, RSV, which can… June 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 Aug 2016Bavarian Nordic gets hold of Opdivo for new Combination Phase II trial Just after a major clinical failure, BMS is now shipping Opdivo to Bavarian Nordic for a Phase II trial. Sponsored… August 17, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 24 May 2016Danish ‘safer’ vaccine for Smallpox gets US order worth €90M Bavarian Nordic will receive €90M from the US' BARDA for its nonreplicating smallpox vaccine - which can be administered to people… May 24, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 May 2016Here are 12 Biotechs you need to know in Copenhagen – Skål! With its canals, the Little Mermaid and the oldest amusement park in the world, Copenhagen is at the heart of… May 3, 2016 - 6 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 5 Aug 2015Did Bavarian Nordic cheat on its clinical results? The hedge fund Kerrisdale Capital just published a report explaining its position in Bavarian Nordic, showing that the Danish company's… August 5, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2015A 100% Successful Ebola Vaccine Available in a Record Time It's a really good news in the fight against Ebola. A vaccine has shown 100% success to prevent the disease during… August 4, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2015European Union supports Bavarian Nordic to cure Ebola Bavarian Nordic has been granted €50M loan from the European Investment Bank (EIB) to support the companies’ pipeline including novel… May 15, 2015 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2015Bristol-Myers Squibb signs an agreement for Bavarian Nordic’s PROSTVAC Bristol-Myers Squibb signs an exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer immunotherapy. Bavarian Nordic will receive… March 4, 2015 - 2 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email